XML 29 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Class B Common Stock
Common Stock
Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020       771,014,000 54,745,000      
Beginning balance at Dec. 31, 2020 $ 3,039,336     $ 7,710 $ 547 $ 6,640,763 $ (3,491,069) $ (118,615)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (340,820)           (340,820)  
Other comprehensive income (loss), net of tax 49,642             49,642
Issuance of common stock, net of expenses (in shares)       69,667,000        
Issuance of common stock, net of expenses 568,609     $ 697   567,912    
Dividends, including dividends reinvested in common stock (in shares)       0        
Dividends, including dividends reinvested in common stock (119,150)         (4) (119,154)  
Share-based compensation expense 61,237         61,237    
Contingent forward purchase contract 0              
Transactions related to employee share-based compensation plans and other (in shares)       6,145,000        
Transactions related to employee share-based compensation plans and other (10,135)     $ 61   (8,649) (1,547)  
Ending balance (in shares) at Dec. 31, 2021       846,826,000 54,745,000      
Ending balance at Dec. 31, 2021 3,248,719     $ 8,468 $ 547 7,261,267 (3,952,590) (68,973)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 132,663           132,663  
Other comprehensive income (loss), net of tax 21,773             21,773
Issuance of common stock, net of expenses (in shares)       140,681,000        
Issuance of common stock, net of expenses 1,189,895     $ 1,407   1,188,488    
Repurchases of common stock (in shares)       (133,333,000)        
Repurchases of common stock (1,094,667)     $ (1,333)   (1,093,334)    
Dividends, including dividends reinvested in common stock (127,835)           (127,835)  
Share-based compensation expense 66,566         66,566    
Contingent forward purchase contract (41,938)         (41,938)    
Transactions related to employee share-based compensation plans and other (in shares)       7,924,000        
Transactions related to employee share-based compensation plans and other (2,028)     $ 79   (290) (1,817)  
Ending balance (in shares) at Dec. 31, 2022   862,098,041 54,744,525 862,098,000 54,745,000      
Ending balance at Dec. 31, 2022 3,393,148     $ 8,621 $ 547 7,380,759 (3,949,579) (47,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 463,009           463,009  
Other comprehensive income (loss), net of tax 31,038             31,038
Dividends (129,025)           (129,025)  
Share-based compensation expense 51,137         51,137    
Contingent forward purchase contract 0         (42,000)    
Transactions related to employee share-based compensation plans and other (in shares)       5,334,000        
Transactions related to employee share-based compensation plans and other (20,661)     $ 53   (18,591) (2,123)  
Ending balance (in shares) at Dec. 31, 2023   867,432,337 54,744,525 867,432,000 54,745,000      
Ending balance at Dec. 31, 2023 $ 3,788,646     $ 8,674 $ 547 $ 7,413,305 $ (3,617,718) $ (16,162)